Crossmark

Letter to Editor for “European Association of Nuclear Medicine (EANM) response to the proposed ASTRO’s framework for radiopharmaceutical therapy curriculum development for trainees.”

Crossref DOI link: https://doi.org/10.1007/s00259-022-06079-y

Published Online: 2022-12-13

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bashir, Humayun

Younis, Muhammad Numair

Naseer, Hamid
License Information

Text and Data Mining valid from 2022-12-13

Version of Record valid from 2022-12-13
More Information

Article History

Received: 16 November 2022

Accepted: 3 December 2022

First Online: 13 December 2022

Declarations

: All authors are responsible for the contents of this letter-to-editor manuscript.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below